Parker T W, Mettler F A, Christie J H, Williams A G
Radiology. 1984 Feb;150(2):547-50. doi: 10.1148/radiology.150.2.6318261.
A survey was conducted to determine the radiopharmaceuticals and radionuclide imaging methods used for thyroid studies in the U.S. in 1981. The final sample, made up of 299 hospitals, was taken from a random sample consisting of 10% (337) of U.S. hospitals performing nuclear medicine studies. The survey showed that over one half of thyroid scans were obtained with Tc-99m pertechnetate and over one half of uptake studies were performed with I-131. Uptake determinations accompanied 78% of scans. Only 8% of the uptake studies were performed without scans. I-123 was more commonly used on the west coast and in the northeast, and there was interest in a more readily available and less expensive supply of I-123. Thyroid studies accounted for 6.7% of all nuclear imaging procedures. Approximately 7,760,000 nuclear medicine imaging procedures were performed in the U.S. in 1981.
1981年在美国进行了一项调查，以确定用于甲状腺研究的放射性药物和放射性核素成像方法。最终样本由299家医院组成，取自美国开展核医学研究医院的10%（337家）的随机样本。调查显示，超过一半的甲状腺扫描是用高锝[99mTc]酸盐进行的，超过一半的摄取研究是用碘[131I]进行的。78%的扫描伴有摄取测定。只有8%的摄取研究没有进行扫描。碘[123I]在西海岸和东北部地区使用更为普遍，人们希望能有更易获取且价格更低廉的碘[123I]供应。甲状腺研究占所有核成像检查的6.7%。1981年美国大约进行了776万次核医学成像检查。
